Overview
Cordarone was a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat recurrent ventricular fibrillation and recurrent hemodynamically unstable ventricular tachycardia. Cordarone was referred to by its drug name, amiodarone.

Cordarone was an antiarrhythmic agent. It was believed to work by influencing the electrical system of the heart.

How was it taken?

Prescribing information stated that Cordarone was generally taken one or more times daily after loading doses had been completed in a clinical setting.

Cordarone came in tablet form.

Side effects
The FDA-approved label for Cordarone listed common side effects including dizziness, fatigue, weakness, insomnia, sensation of warmth or tingling under the skin, heart failure, pulmonary fibrosis, nausea, vomiting, constipation, abdominal pain, and loss of appetite.

Rare but serious side effects listed for Cordarone included potentially fatal toxicity to the lungs and liver.

For more details about this treatment, visit:
Cordarone — Drugs.com